Search Results - "Bohn, Uriel"
-
1
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Published in Clinical cancer research (15-04-2018)“…Triple-negative breast cancer (TNBC) requires the iden- tification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we…”
Get full text
Journal Article -
2
Information needs and research priorities in long‐term survivorship of breast cancer: Patients and health professionals' perspectives
Published in European journal of cancer care (01-11-2022)“…Objective The objective of this work is to identify unmet information needs of long‐term‐survivors of breast cancer (BC) and future research needs from the…”
Get full text
Journal Article -
3
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer
Published in PloS one (20-01-2015)“…Studies suggest a relationship between hypertension and outcome in bevacizumab-treated patients with metastatic colorectal cancer (mCRC). We performed a…”
Get full text
Journal Article -
4
Cross-cultural adaptation, reliability and validity of the Spanish version of the long-term quality of life questionnaire
Published in Frontiers in oncology (19-03-2024)“…The aim of this study was to translate, culturally adapt, and evaluate the psychometric properties of the Spanish Long-Term Quality of Life (LTQL)…”
Get full text
Journal Article -
5
Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast
Published in The breast journal (01-03-2007)“…Nonislet cell tumor hypoglycemia (NICTH) is uncommon, and has been related to the production of insulin-like growth factor II or its high-molecular-weight…”
Get more information
Journal Article -
6
Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy
Published in Journal of clinical oncology (10-05-2016)“…To describe estradiol (E2), estrone (E1), and estrone sulfate (E1S) levels during the first year of monthly triptorelin plus exemestane or tamoxifen and to…”
Get full text
Journal Article -
7
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy
Published in Clinical cancer research (15-05-2024)“…Stromal tumor-infiltrating lymphocytes (sTIL) are associated with pathologic complete response (pCR) and long-term outcomes for triple-negative breast cancer…”
Get full text
Journal Article -
8
Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
Published in Clinical & translational oncology (01-09-2009)“…Background The results of CHOP-21 (cyclophosphamide, doxorubicin, vincristine and prednisone given every 21 days) for the treatment of aggressive B-cell…”
Get full text
Journal Article -
9
Abstract PS4-12: Potential value of FOXA1 expression as genomic predictor of response to docetaxel and carboplatin neoadjuvant (NA) chemotherapy in patients with triple negative breast cancer (TNBC)
Published in Cancer research (Chicago, Ill.) (15-02-2021)“…Abstract Background: TNBC is a particularly aggressive subtype with high recurrence rates and poor long-term survival. Anthracycline-free regimens based on…”
Get full text
Journal Article -
10
A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial—A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
11
Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)
Published in The oncologist (Dayton, Ohio) (01-11-2019)“…Background RAS testing is used to select patients with anti‐epidermal growth factor receptor (EGFR) therapies sensitivity in metastatic colorectal cancer…”
Get full text
Journal Article -
12
Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer
Published in Journal of cancer research and clinical oncology (01-05-2006)“…To assess the efficacy and the toxicity of a new combination of epirubicin, cyclophosphamide and paclitaxel as neoadjuvant chemotherapy for breast cancer…”
Get full text
Journal Article -
13
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
Published in European journal of endocrinology (01-10-2017)“…Background Axitinib, an antiangiogenic multikinase inhibitor (MKI), was evaluated in the compassionate use programme (CUP) in Spain (October 2012–November…”
Get full text
Journal Article -
14
Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone
Published in Hematological oncology (01-09-2014)“…There is no standard treatment for patients with gastric marginal zone B‐cell lymphoma of the mucosa‐associated lymphoid tissue (MALT lymphoma) who are…”
Get full text
Journal Article -
15
Some unusual paraneoplastic syndromes. Case 1. Metastatic squamous cell esophageal cancer to the thumb
Published in Journal of clinical oncology (01-07-2003)Get full text
Journal Article -
16
Abstract PS16-07: Tumor infiltrating lymphocyte stratification refines AJCC TNM staging based outcomes of early-stage triple negative breast cancer treated with neoadjuvant anthracycline-free, docetaxel and carboplatin chemotherapy
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Abstract Background: Stromal tumor-infiltrating lymphocytes (sTILs) quantification is associated with pathological response to neoadjuvant chemotherapy (NAC)…”
Get full text
Journal Article -
17
Lumbar region intra-spinal primitive neuroectodermal tumour (PNET) combined with neurofibromatosis type 1
Published in Clinical & translational oncology (01-11-2005)“…Primitive neuroectodermal tumours (PNET) are aggressive neoplasias that are diagnosed, usually, in infancy. Their appearance in adulthood is rare and,…”
Get full text
Journal Article -
18
Soft tissue sarcomas: A challenge for oncology
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
19
Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene ( EGFR ) mutation testing
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
20
GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
Published in Future science OA (01-02-2019)“…Response to polyadenosine diphosphate ribose polymerase ( ) inhibitors in platinum-resistant ovarian cancer and in the absence of mutations is very low…”
Get full text
Journal Article